The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
AusPAR: Opdualag
Australian Public Assessment Report
Device/Product Name
Opdualag
Active ingredients
Nivolumab and Relatlimab
AusPAR Date
Published
Submission Number
PM 2021-03689-1-4
Submission Type
New combination
Decision
Approved